Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

POWERSHARES DYNAMIC PHARMACEUTICALS PORT: (PJP)

(Market Close from AMEX) As of Oct 20, 2014 03:59 PM ET

 Add to portfolio

$62.91 USD

+0.98 (1.58%)

Volume: 221,752

Zacks ETF Rank: 4 - Sell [?]       4  

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 61.93
Open 61.88
Bid 60.52
Ask 63.00
Day Low-High 61.87-62.92
52wk Low-High 47.26-65.22
Volume 221,752
NAV (month end) 63.62
Premium (+)/Discount (-) (month end)-1.69

Zacks Premium Research for PJP

Zacks ETF Rank [?] Sell 4
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.58%
Dividend (Yield) $0.29 (0.47%)
Issuer INVESCO POWERSHARES

Benchmark for PJP

DYNAMIC PHARMACEUTICALS INTELLIDEX INDEX

The index is comprised of stocks of U.S. pharmaceutical companies. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Fund Summary for PJP

POWERSHARES DYNAMIC PHARMACEUTICALS PORT

It is based on the Dynamic Pharmaceuticals Intellidex Index. It invests at least 90% of its assets in common stocks comprising the Index which provides capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.